277 related articles for article (PubMed ID: 16784541)
1. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.
Porco TC; Lewis B; Marseille E; Grinsdale J; Flood JM; Royce SE
BMC Public Health; 2006 Jun; 6():157. PubMed ID: 16784541
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.
Dasgupta K; Schwartzman K; Marchand R; Tennenbaum TN; Brassard P; Menzies D
Am J Respir Crit Care Med; 2000 Dec; 162(6):2079-86. PubMed ID: 11112118
[TBL] [Abstract][Full Text] [Related]
3. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
[TBL] [Abstract][Full Text] [Related]
4. Disease Surveillance Among U.S.-Bound Immigrants and Refugees - Electronic Disease Notification System, United States, 2014-2019.
Phares CR; Liu Y; Wang Z; Posey DL; Lee D; Jentes ES; Weinberg M; Mitchell T; Stauffer W; Self JL; Marano N
MMWR Surveill Summ; 2022 Jan; 71(2):1-21. PubMed ID: 35051136
[TBL] [Abstract][Full Text] [Related]
5. Domestic returns from investment in the control of tuberculosis in other countries.
Schwartzman K; Oxlade O; Barr RG; Grimard F; Acosta I; Baez J; Ferreira E; Melgen RE; Morose W; Salgado AC; Jacquet V; Maloney S; Laserson K; Mendez AP; Menzies D
N Engl J Med; 2005 Sep; 353(10):1008-20. PubMed ID: 16148286
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of LTBI treatment for TB contacts in British Columbia.
Tan MC; Marra CA; Sadatsafavi M; Marra F; Morán-Mendoza O; Moadebi S; Elwood RK; FitzGerald JM
Value Health; 2008; 11(5):842-52. PubMed ID: 18489519
[TBL] [Abstract][Full Text] [Related]
7. National position statement for the management of latent tuberculosis infection.
Stock D;
Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
[TBL] [Abstract][Full Text] [Related]
8. Public health interventions to encourage TB class A/B1/B2 immigrants to present for TB screening.
Catlos EK; Cantwell MF; Bhatia G; Gedin S; Lewis J; Mohle-Boetani JC
Am J Respir Crit Care Med; 1998 Oct; 158(4):1037-41. PubMed ID: 9769257
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
Snyder DC; Paz EA; Mohle-Boetani JC; Fallstad R; Black RL; Chin DP
Am J Respir Crit Care Med; 1999 Jul; 160(1):178-85. PubMed ID: 10390397
[TBL] [Abstract][Full Text] [Related]
10. Disease surveillance among newly arriving refugees and immigrants--Electronic Disease Notification System, United States, 2009.
Lee D; Philen R; Wang Z; McSpadden P; Posey DL; Ortega LS; Weinberg MS; Brown C; Zhou W; Painter JA;
MMWR Surveill Summ; 2013 Nov; 62(7):1-20. PubMed ID: 24225411
[TBL] [Abstract][Full Text] [Related]
11. Outlook for tuberculosis elimination in California: An individual-based stochastic model.
Goodell AJ; Shete PB; Vreman R; McCabe D; Porco TC; Barry PM; Flood J; Marks SM; Hill A; Cattamanchi A; Kahn JG
PLoS One; 2019; 14(4):e0214532. PubMed ID: 30964878
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
13. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
[TBL] [Abstract][Full Text] [Related]
14. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of isoniazid chemoprevention in close contacts.
Diel R; Nienhaus A; Schaberg T
Eur Respir J; 2005 Sep; 26(3):465-73. PubMed ID: 16135730
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.
Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC
J Urban Health; 2001 Sep; 78(3):550-67. PubMed ID: 11564856
[TBL] [Abstract][Full Text] [Related]
17. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
[TBL] [Abstract][Full Text] [Related]
18. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis.
Macintyre CR; Plant AJ; Hendrie D
Health Econ; 2000 Jul; 9(5):411-21. PubMed ID: 10903541
[TBL] [Abstract][Full Text] [Related]
20. Priorities for screening and treatment of latent tuberculosis infection in the United States.
Linas BP; Wong AY; Freedberg KA; Horsburgh CR
Am J Respir Crit Care Med; 2011 Sep; 184(5):590-601. PubMed ID: 21562129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
